ENDOU — Endonuclease Poly(U) Polypeptide

ENDOU — Endonuclease Poly(U) Polypeptide

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">endou</th>
</tr>
<tr>
<td class="label">Domain</td>
<td>Function</td>
</tr>
<tr>
<td class="label">N-terminal signal peptide</td>
<td>Secretory pathway targeting</td>
</tr>
<tr>
<td class="label">Catalytic domain</td>
<td>Endonuclease activity</td>
</tr>
<tr>
<td class="label">RNA-binding region</td>
<td>Substrate recognition</td>
</tr>
<tr>
<td class="label">Dimerization interface</td>
<td>Functional complex formation</td>
</tr>
<tr>
<td class="label">Protein</td>
<td>Interaction with ENDOU</td>
</tr>
<tr>
<td class="label">TDP-43</td>
<td>Co-localization in stress granules</td>
</tr>
<tr>
<td class="label">FUS</td>
<td>Potential interaction</td>
</tr>
<tr>
<td class="label">TIA1</td>
<td>Stress granule component</td>
</tr>
<tr>
<td class="label">OPTN</td>
<td>Autophagy receptor</td>
</tr>
<tr>
<td class="label">p62/SQSTM1</td>
<td>Selective autophagy</td>
</tr>
<tr>
<td class="label">Method</td>
<td>Application</td>
</tr>
<tr>
<td class="label">qPCR</td>
<td>mRNA expression</td>
</tr>
<tr>
<td class="label">Western blot</td>
<td>Protein levels</td>
</tr>
<tr>
<td class="label">Immunohistochemistry</td>
<td>Tissue localization</td>
</tr>
<tr>
<td class="label">RNA-seq</td>
<td>Transcriptome analysis</td>
</tr>
<tr>
<td class="label">Ribosome profili

ENDOU — Endonuclease Poly(U) Polypeptide

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">endou</th>
</tr>
<tr>
<td class="label">Domain</td>
<td>Function</td>
</tr>
<tr>
<td class="label">N-terminal signal peptide</td>
<td>Secretory pathway targeting</td>
</tr>
<tr>
<td class="label">Catalytic domain</td>
<td>Endonuclease activity</td>
</tr>
<tr>
<td class="label">RNA-binding region</td>
<td>Substrate recognition</td>
</tr>
<tr>
<td class="label">Dimerization interface</td>
<td>Functional complex formation</td>
</tr>
<tr>
<td class="label">Protein</td>
<td>Interaction with ENDOU</td>
</tr>
<tr>
<td class="label">TDP-43</td>
<td>Co-localization in stress granules</td>
</tr>
<tr>
<td class="label">FUS</td>
<td>Potential interaction</td>
</tr>
<tr>
<td class="label">TIA1</td>
<td>Stress granule component</td>
</tr>
<tr>
<td class="label">OPTN</td>
<td>Autophagy receptor</td>
</tr>
<tr>
<td class="label">p62/SQSTM1</td>
<td>Selective autophagy</td>
</tr>
<tr>
<td class="label">Method</td>
<td>Application</td>
</tr>
<tr>
<td class="label">qPCR</td>
<td>mRNA expression</td>
</tr>
<tr>
<td class="label">Western blot</td>
<td>Protein levels</td>
</tr>
<tr>
<td class="label">Immunohistochemistry</td>
<td>Tissue localization</td>
</tr>
<tr>
<td class="label">RNA-seq</td>
<td>Transcriptome analysis</td>
</tr>
<tr>
<td class="label">Ribosome profiling</td>
<td>Translation status</td>
</tr>
<tr>
<td class="label">Cell Type</td>
<td>Expression Level</td>
</tr>
<tr>
<td class="label">Pyramidal neurons</td>
<td>High</td>
</tr>
<tr>
<td class="label">Purkinje cells</td>
<td>High</td>
</tr>
<tr>
<td class="label">Dopaminergic neurons</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">Astrocytes</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">Oligodendrocytes</td>
<td>Low</td>
</tr>
<tr>
<td class="label">Target</td>
<td>Strategy</td>
</tr>
<tr>
<td class="label">ENDOU expression</td>
<td>Transcriptional modulators</td>
</tr>
<tr>
<td class="label">ENDOU activity</td>
<td>Small molecule inhibitors</td>
</tr>
<tr>
<td class="label">ENDOU partners</td>
<td>Protein-protein interaction</td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>

Gene Symbol: ENDOU Gene Name: Endonuclease Poly(U) Polypeptide (Endonuclease U) Chromosomal Location: 12p11.2 NCBI Gene ID: 20968 Ensembl ID: ENSG00000123636 UniProt ID: P58387

Gene Overview

ENDOU encodes Endonuclease U (Poly(U) hydrolase), a member of the endonuclease family that specifically hydrolyzes poly(U) RNA substrates. This enzyme possesses both RNase and RNase inhibitor activity, playing crucial roles in RNA processing, degradation, and quality control. ENDOU is expressed in various tissues, including the brain, where it participates in neuronal RNA metabolism relevant to neurodegenerative processes [1](https://pubmed.ncbi.nlm.nih.gov/10625666/).

Normal Function

Enzyme Activity and Substrate Specificity

ENDOU is a secreted or cytoplasmic endonuclease with unique substrate specificity[@endorib]:

• Poly(U) Specificity: Preferentially cleaves RNA molecules containing poly(U) sequences
• Endonucleolytic Cleavage: Makes internal cuts in RNA substrates
• RNase Inhibitor Sensitivity: Activity is modulated by RNase inhibitor proteins
• Metal Ion Dependence: Requires magnesium or manganese ions for catalytic activity[@polyu]

Structural Features

The ENDOU protein contains:

Cellular Functions

Brain Expression

In the nervous system, ENDOU is expressed in:

• [Neurons](/entities/neurons) throughout the [cortex](/brain-regions/cortex) and [hippocampus](/brain-regions/hippocampus)
• [Astrocytes](/entities/astrocytes) and oligodendrocytes
• Synaptic vesicles (potential role in synaptic RNA regulation)

RNA Metabolism Pathways

Disease Associations

Alzheimer's Disease (AD)

In Alzheimer's disease, ENDOU may play protective or pathological roles[@ad_rna]:

The RNA metabolism hypothesis of AD:

• Global dysregulation of RNA processing
• Accumulation of aberrant RNAs
• Impaired RNA quality control
• ENDOU as compensatory mechanism

Parkinson's Disease (PD)

In Parkinson's disease[@pd_rna]:

• Dopaminergic vulnerability: ENDOU expression altered in substantia nigra
• RNA quality control: May degrade misfolded RNAs associated with PD
• Stress granules: Potential role in stress granule dynamics[@stress_granules]
• α-Synuclein connection: Possible interplay with RNA metabolism

Neurodevelopmental Disorders

ENDOU has been implicated in brain development:

• Mutations or alterations affect neuronal development
• Potential involvement in intellectual disability
• May affect synaptic RNA regulation

Cancer

Interestingly, ENDOU shows dual roles[@cancer_endou]:

• Overexpression: In various cancers (glioblastoma, breast cancer)
• Tumor support: May support tumor growth through RNA regulation
• Biomarker potential: Diagnostic and prognostic applications
• Therapeutic target: Selective inhibition strategies

Mechanisms of Neurodegeneration

The relationship between ENDOU dysfunction and neurodegeneration:

Molecular Mechanisms

RNA Quality Control Pathways

ENDOU participates in multiple RNA quality control mechanisms:

• Ribosome-associated quality control (RQC)
• No-go decay (NGD)
• Collision-induced quality control

• Nonsense-mediated decay (NMD)[@nmd_pathway]
• Staufen-mediated decay (SMD)
• TGS-mediated decay

• Ribosome stalling response
• ENDOU-mediated degradation

Stress Granule Dynamics

Stress granules are membrane-less organelles that form under stress[@stress_granules]:

ENDOU may modulate stress granule dynamics through:

• Direct granule recruitment
• RNA cargo processing within granules
• Granule disassembly regulation

Interaction with Neurodegeneration Proteins

Clinical Significance

Diagnostic Biomarkers

ENDOU as a biomarker:

• Blood/CSF levels: Altered in neurodegenerative disease
• Expression patterns: Disease-specific signatures
• Correlation with progression: Potential disease marker
• Advantage: Accessible, minimally invasive

Therapeutic Target Validation

Rationale for targeting ENDOU:

• Central position in RNA metabolism
• Disease-associated expression changes
• Druggable protein structure
• Accessible to small molecule modulation

Cellular Stress Response

Endoplasmic Reticulum Stress

ENDOU in the unfolded protein response:

• Links protein and RNA homeostasis
• May regulate IRE1/XBP1 pathway
• Potential for integrated stress response

Oxidative Stress

Under oxidative stress:

• ENDOU expression upregulated
• Protects against RNA oxidation
• Maintains translation capacity

Mitochondrial Stress

Cross-talk with mitochondrial function:

• Mitochondrial RNA processing
• Cytosolic RNA quality control
• Metabolic stress response

Evolutionary Perspective

Conservation

• ENDOU is conserved across eukaryotes
• Orthologs in model organisms (yeast, fly, zebrafish)
• Functional conservation of poly(U) specificity

Gene Family

• Member of the endoribonuclease family
• Related to poly(U) polymerases
• Distinct from other RNase families

Research Methods

Detection Techniques

Functional Studies

• Knockdown/knockout approaches
• Overexpression studies
• Enzyme activity assays
• Protein interaction mapping

Future Directions

Unanswered Questions

Emerging Research

• Single-cell RNA analysis
• Proteomics of stress granules
• Structural biology of ENDOU
• In vivo imaging of RNA dynamics

Key Publications

Cross-References

• [RNA Metabolism](/mechanisms/rna-metabolism)
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• [Stress Granules](/mechanisms/stress-granules)
• [RNAi and Small RNAs](/mechanisms/rna-interference)

Expression Pattern

Brain Regional Distribution

ENDOU is expressed in multiple brain regions:

• Cortex: Pyramidal neurons throughout cortical layers
• Hippocampus: High expression in CA1-CA3 and dentate gyrus
• Cerebellum: Purkinje cells and granule cells
• Brainstem: Various neuronal populations
• Spinal Cord: Motor neurons

Subcellular Localization

• Cytoplasm: Primary location
• Secretory Pathway: Can be secreted extracellularly
• Nucleus: Limited nuclear localization in some cell types
• Synaptic vesicles: Potential role in synaptic RNA regulation

Cellular Distribution

Therapeutic Implications

Neurodegeneration

Targeting ENDOU for therapeutic benefit:

Drug Development Targets

Cancer Therapy

• ENDOU as biomarker: Diagnostic and prognostic marker
• Selective inhibition: Targeting tumor-specific overexpression
• Antibody-drug conjugates: ENDOU-directed therapy
• Combination approaches: With standard chemotherapy

Research and Model Systems

Animal Models

Current understanding from model systems:

• Knockout mice show viability and fertility
• Subtle neurological phenotypes
• RNA processing abnormalities
• Cancer predisposition in some models

Cell Culture Studies

• Neuronal differentiation models
• Stress response paradigms
• Amyloid toxicity models
• α-Synuclein aggregation studies

Interaction Network

flowchart LR
subgraph RNA Binding Proteins
ENDOU --> TDP43["TDP-43"]
ENDOU --> FUS["FUS"]
ENDOU --> TIA1["TIA1"]
end

subgraph Pathways
ENDOU --> SPLICING["RNA Splicing"]
ENDOU --> NMD["NMD"]
ENDOU --> RQC["Ribosome Quality Control"]
end

subgraph Disease Links
TDP43 ==> AD["Alzheimer's Disease"]
FUS ==> FTD["Frontotemporal Dementia"]
NMD ==> NEURO["Neurodegeneration"]
end

See Also

• [RNA Metabolism](/mechanisms/rna-metabolism)
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• [Stress Granules](/mechanisms/stress-granules)
• [RNAi and Small RNAs](/mechanisms/rna-interference)
• [TDP-43](/proteins/tdp-43)
• [FUS Protein](/proteins/fus-protein)
• [RNA Quality Control](/mechanisms/rna-quality-control)
• [Neuroprotection](/therapeutics/neuroprotection)

References